My father has dementia and is in a care home—he has been during covid—so I know that it is really important to make significant advances in this field. One of the difficulties for business that are trying to take great scientific and medical ideas into the market is that it is much more costly if we have a different regulatory regime in this country from the rest of Europe. Will the Secretary of State ensure that we align our regulatory regime in this field with the rest of Europe, rather than diverge from it?
Budget Resolutions and Economic Situation
Proceeding contribution from
Chris Bryant
(Labour)
in the House of Commons on Monday, 20 March 2023.
It occurred during Budget debate on Budget Resolutions and Economic Situation.
Type
Proceeding contribution
Reference
730 c46
Session
2022-23
Chamber / Committee
House of Commons chamber
Subjects
Librarians' tools
Timestamp
2023-03-21 10:18:47 +0000
URI
http://hansard.intranet.data.parliament.uk/Commons/2023-03-20/23032028000027
In Indexing
http://indexing.parliament.uk/Content/Edit/1?uri=http://hansard.intranet.data.parliament.uk/Commons/2023-03-20/23032028000027
In Solr
https://search.parliament.uk/claw/solr/?id=http://hansard.intranet.data.parliament.uk/Commons/2023-03-20/23032028000027